azacitidine has been researched along with ds-5272 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, KS; Darbaniyan, F; Daver, N; Do, KA; Ganan-Gomez, I; Garcia-Manero, G; Kanagal-Shamanna, R; Li, Z; Lockyer, PP; Montalban-Bravo, G; Soltysiak, KA; Wei, Y; Yang, H; Zheng, H | 1 |
1 other study(ies) available for azacitidine and ds-5272
| Article | Year |
|---|---|
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Topics: Animals; Azacitidine; Imidazoles; Leukemia, Myelomonocytic, Chronic; Mice; Myelodysplastic Syndromes | 2022 |